Container Closure Integrity (CCI) Analytical Procedures

Vacuum Decay is a deterministic, non-destructive analytical procedure used to evaluate the Container Closure Integrity (CCI) of sterile pharmaceutical products such as vials, syringes, ampoules, and cartridges. The method detects microleaks that could compromise sterility or stability by monitoring pressure changes in a vacuum chamber containing the sealed container.
Recognized under USP <1207.2>, Vacuum Decay has become a gold-standard alternative to probabilistic dye ingress tests and is widely adopted across biologics and advanced therapy manufacturing.

Legacy:

Dye Ingress Test (USP <1071>) – qualitative, destructive, and operator-dependent; sensitivity limited to ~10–20 µm leaks.

Established Standard:

Vacuum Decay (USP <1207.2>) – deterministic, quantitative, and non-destructive. Provides validated leak detection sensitivity (≤2 µm equivalent defect size) with full electronic traceability.

Future:

Integration with Helium Leak and Laser-Based Gas Headspace Analysis for complementary detection.

Inline / at-line automation within filling and packaging lines for 100% inspection under GMP.

Enhanced digital traceability and model-based leak simulation for lifecycle validation.

A sealed container is placed inside a vacuum test chamber.

The chamber is evacuated to a defined pressure.

The system monitors for pressure rise over a fixed time interval.

A stable pressure indicates an intact closure; a pressure increase signifies gas leakage through a microdefect.
Leak detection is based on Boyle’s Law, correlating pressure change to leak size.

Because it is a quantitative measurement of gas flow, Vacuum Decay avoids the subjectivity of visual tests and provides consistent, reproducible data across operators and sites.

Output: Quantitative pressure decay curve (pressure vs. time).

Pass/Fail Determination: Defined by a validated acceptance limit (e.g., <1×10⁻³ mbar/s pressure rise).

Interpretation:

Stable pressure → Pass (no leak).

Detectable pressure rise → Fail (leak detected).

Reportable Value: Pressure rise or leak rate in mbar/s or Pa/s, stored with batch metadata.

Deterministic and scientifically justified per USP <1207.1>.

Non-destructive — samples can be reintroduced to the batch.

Applicable to multiple container formats and sizes.

Quantitative and fully traceable electronic data output.

Can be validated as an alternative to dye ingress testing.

Requires container-specific method development and calibration.

Performance influenced by container geometry and material (e.g., elastomeric stoppers, glass thickness).

High-capacity systems can be cost-intensive for low-volume products.

Accuracy / Detection Limit: Must demonstrate detection of leaks equivalent to or smaller than the product’s maximum allowable leak limit (MALL).

Precision: Evaluate repeatability and intermediate precision across runs and operators.

Specificity: Confirm no false positives/negatives using known-leak standards.

System Suitability: Daily verification using calibrated leak standards.

Method Robustness: Assess across vacuum levels, dwell times, and temperature variations.

Reference leaks (calibrated capillaries or laser-drilled holes) traceable to NIST standards.

System calibration per USP <1207.1> Annex and ASTM F2338.

Lifecycle qualification includes installation, operational, and performance verification (IQ/OQ/PQ).

AAV and mRNA Drug Products: Ensures sterile barrier integrity of final vials or syringes containing sensitive biologics.

Cell Therapies: Critical for cryovials and pre-filled bags to prevent contamination during freezing or storage.

Protein / mAb Products: Prevents microbial ingress and moisture exchange in lyophilized vials.

Combination Products: Used to validate seal integrity of prefilled syringe systems and autoinjectors.